MR. ROBIN HU YEE CHENG
Independent Director; Chairman of the Board of Directors; Member of the Audit and Risk Committee
Board of Directors / Manager1 July 2025
Director appointmentThe business, the people and the ownership behind ParkwayLife Reit.
Business overview
Parkway Life REIT invests in healthcare and healthcare-related real estate. Its investment scope includes hospitals, nursing homes and other properties used for healthcare services, research, education and related purposes.
Listed security
Board & management
Independent Director; Chairman of the Board of Directors; Member of the Audit and Risk Committee
Board of Directors / Manager1 July 2025
Director appointmentIndependent Director; Chairman of the Nominating and Remuneration Committee; Member of the Audit and Risk Committee
Board of Directors / Manager25 October 2024
Director appointment21 April 2025
Director endorsementIndependent Director; Chairman of the Audit and Risk Committee; Member of the Nominating and Remuneration Committee
Board of Directors / Manager20 October 2025
Director appointmentNon-Independent Non-Executive Director
Board of Directors / Manager17 November 2023
Director appointment30 April 2024
Director endorsementNon-Independent Non-Executive Director; Member of Nominating and Remuneration Committee
Board of Directors / Manager17 November 2023
Director appointment30 April 2024
Director endorsementNon-Independent Non-Executive Director
Board of Directors / Manager17 November 2023
Director appointment30 April 2024
Director endorsementNon-Independent Non-Executive Director
Board of Directors / Manager5 December 2023
Director appointment30 April 2024
Director endorsementChief Executive Officer; Executive Director
Board of Directors / Manager29 January 2009
Director appointment24 April 2023
Director endorsementRoles listed in Annual Report 2025; current appointments are not independently verified.
Holdings
The twenty largest registered / depository holders total 559,304,918 units (85.69%) as at 2 March 2026. This aggregate is not an additional holder. Direct and deemed interests of the nine substantial unitholders may overlap; these holdings should not be added together. The directors’ holdings register is dated 21 January 2026.
–
Substantial unitholdings as at 2 March 2026; direct interest As reported at 2 March 2026215,105,128
Substantial unitholdings as at 2 March 2026; deemed interest As reported at 2 March 2026–
Substantial unitholdings as at 2 March 2026; direct interest As reported at 2 March 2026215,105,128
Substantial unitholdings as at 2 March 2026; deemed interest As reported at 2 March 2026–
Substantial unitholdings as at 2 March 2026; direct interest As reported at 2 March 2026215,105,128
Substantial unitholdings as at 2 March 2026; deemed interest As reported at 2 March 2026–
Substantial unitholdings as at 2 March 2026; direct interest As reported at 2 March 2026215,105,128
Substantial unitholdings as at 2 March 2026; deemed interest As reported at 2 March 2026–
Substantial unitholdings as at 2 March 2026; direct interest As reported at 2 March 2026215,105,128
Substantial unitholdings as at 2 March 2026; deemed interest As reported at 2 March 2026219,215
Substantial unitholdings as at 2 March 2026; direct interest As reported at 2 March 2026214,885,913
Substantial unitholdings as at 2 March 2026; deemed interest As reported at 2 March 2026–
Substantial unitholdings as at 2 March 2026; direct interest As reported at 2 March 2026214,885,913
Substantial unitholdings as at 2 March 2026; deemed interest As reported at 2 March 2026–
Substantial unitholdings as at 2 March 2026; direct interest As reported at 2 March 2026214,885,913
Substantial unitholdings as at 2 March 2026; deemed interest As reported at 2 March 2026213,257,000
Substantial unitholdings as at 2 March 2026; direct interest As reported at 2 March 2026–
Substantial unitholdings as at 2 March 2026; deemed interest As reported at 2 March 2026Direct interest: 31,000; Deemed interest: –
Units held by directors of the Manager As reported at 21 January 2026Direct interest: –; Deemed interest: –
Units held by directors of the Manager As reported at 21 January 2026Direct interest: –; Deemed interest: –
Units held by directors of the Manager As reported at 21 January 2026Direct interest: –; Deemed interest: –
Units held by directors of the Manager As reported at 21 January 2026Direct interest: –; Deemed interest: –
Units held by directors of the Manager As reported at 21 January 2026Direct interest: –; Deemed interest: –
Units held by directors of the Manager As reported at 21 January 2026Direct interest: –; Deemed interest: –
Units held by directors of the Manager As reported at 21 January 2026Direct interest: –; Deemed interest: 1,101,300
Units held by directors of the Manager As reported at 21 January 2026Total interests include direct and deemed holdings and may overlap across holders. These percentages should not be added together.
Registered holdings, including nominees and depositories; these do not establish ultimate beneficial ownership. As reported at 2 March 2026 · PDF p. 237
| Registered holder | Interest | Shares / units | Source |
|---|---|---|---|
| PARKWAY INVESTMENTS PTE LTD | 213,257,000; 32.68 | PDF p. 2372 March 2026 | |
| CITIBANK NOMINEES SINGAPORE PTE LTD | 118,291,495; 18.12 | PDF p. 2372 March 2026 | |
| DBS NOMINEES (PRIVATE) LIMITED | 66,407,791; 10.18 | PDF p. 2372 March 2026 | |
| HSBC (SINGAPORE) NOMINEES PTE LTD | 48,495,696; 7.43 | PDF p. 2372 March 2026 | |
| RAFFLES NOMINEES (PTE.) LIMITED | 25,335,845; 3.88 | PDF p. 2372 March 2026 | |
| DBSN SERVICES PTE. LTD. | 22,348,881; 3.42 | PDF p. 2372 March 2026 | |
| BPSS NOMINEES SINGAPORE (PTE.) LTD. | 18,670,304; 2.86 | PDF p. 2372 March 2026 | |
| UNITED OVERSEAS BANK NOMINEES (PRIVATE) LIMITED | 7,262,277; 1.11 | PDF p. 2372 March 2026 | |
| ABN AMRO CLEARING BANK N.V. | 7,095,496; 1.09 | PDF p. 2372 March 2026 | |
| IFAST FINANCIAL PTE. LTD. | 5,585,092; 0.86 | PDF p. 2372 March 2026 | |
| PHILLIP SECURITIES PTE LTD | 4,763,910; 0.73 | PDF p. 2372 March 2026 | |
| MOOMOO FINANCIAL SINGAPORE PTE. LTD. | 4,521,086; 0.69 | PDF p. 2372 March 2026 | |
| OCBC NOMINEES SINGAPORE PRIVATE LIMITED | 3,980,937; 0.61 | PDF p. 2372 March 2026 | |
| OCBC SECURITIES PRIVATE LIMITED | 2,972,100; 0.46 | PDF p. 2372 March 2026 | |
| MORGAN STANLEY ASIA (SINGAPORE) SECURITIES PTE LTD | 1,909,445; 0.29 | PDF p. 2372 March 2026 | |
| UOB KAY HIAN PRIVATE LIMITED | 1,859,600; 0.28 | PDF p. 2372 March 2026 | |
| TIGER BROKERS (SINGAPORE) PTE. LTD. | 1,828,400; 0.28 | PDF p. 2372 March 2026 | |
| DB NOMINEES (SINGAPORE) PTE LTD | 1,636,050; 0.25 | PDF p. 2372 March 2026 | |
| PARKWAY TRUST MANAGEMENT LIMITED | 1,628,913; 0.25 | PDF p. 2372 March 2026 | |
| BNP PARIBAS NOMINEES SINGAPORE PTE. LTD. | 1,454,600; 0.22 | PDF p. 2372 March 2026 | |
Group structure
| Company | Market | Ownership interest |
|---|---|---|
| Parkway Life Japan2 Pte. Ltd.Group; effective interest held, 2025 and 2024 respectivelyPDF p. 192 | Investment holding; Singapore; Effective interests held by Group: 100% / 100% | |
| Godo Kaisha Del MonteGroup; effective interest held, 2025 and 2024 respectivelyPDF p. 192 | Special purpose entity – Investment in real estate; Japan; Effective interests held by Group: 100% / 100% | |
| Godo Kaisha Tenshi 1Group; effective interest held, 2025 and 2024 respectivelyPDF p. 192 | Special purpose entity – Investment in real estate; Japan; Effective interests held by Group: 100% / 100% | |
| Godo Kaisha Tenshi 2Group; effective interest held, 2025 and 2024 respectivelyPDF p. 192 | Special purpose entity – Investment in real estate; Japan; Effective interests held by Group: 100% / 100% | |
| G.K. NestGroup; effective interest held, 2025 and 2024 respectivelyPDF p. 192 | Special purpose entity – Investment in real estate; Japan; Effective interests held by Group: 100% / 100% | |
| Godo Kaisha Samurai 19Group; effective interest held, 2025 and 2024 respectivelyPDF p. 192 | Special purpose entity – Investment in real estate; Japan; Effective interests held by Group: 100% / 100% | |
| Godo Kaisha Samurai 20Group; effective interest held, 2025 and 2024 respectivelyPDF p. 192 | Special purpose entity – Investment in real estate; Japan; Effective interests held by Group: 100% / 100% | |
| Parkway Life Japan3 Pte. Ltd.Group; effective interest held, 2025 and 2024 respectivelyPDF p. 192 | Investment holding; Singapore; Effective interests held by Group: 100% / 100% | |
| Godo Kaisha Healthcare 1Group; effective interest held, 2025 and 2024 respectivelyPDF p. 192 | Special purpose entity – Investment in real estate; Japan; Effective interests held by Group: 100% / 100% | |
| Godo Kaisha Healthcare 2Group; effective interest held, 2025 and 2024 respectivelyPDF p. 192 | Special purpose entity – Investment in real estate; Japan; Effective interests held by Group: 100% / 100% | |
| Godo Kaisha Healthcare 3Group; effective interest held, 2025 and 2024 respectivelyPDF p. 192 | Special purpose entity – Investment in real estate; Japan; Effective interests held by Group: 100% / 100% | |
| Godo Kaisha Healthcare 4Group; effective interest held, 2025 and 2024 respectivelyPDF p. 192 | Special purpose entity – Investment in real estate; Japan; Effective interests held by Group: 100% / 100% | |
| Godo Kaisha Healthcare 5Group; effective interest held, 2025 and 2024 respectivelyPDF p. 192 | Special purpose entity – Investment in real estate; Japan; Effective interests held by Group: 100% / 100% | |
| Parkway Life Japan4 Pte. Ltd.Group; effective interest held, 2025 and 2024 respectivelyPDF p. 193 | Investment holding; Singapore; Effective interests held by Group: 100% / 100% | |
| Godo Kaisha SamuraiGroup; effective interest held, 2025 and 2024 respectivelyPDF p. 193 | Special purpose entity – Investment in real estate; Japan; Effective interests held by Group: 100% / 100% | |
| Godo Kaisha Samurai 2Group; effective interest held, 2025 and 2024 respectivelyPDF p. 193 | Special purpose entity – Investment in real estate; Japan; Effective interests held by Group: 100% / 100% | |
| Godo Kaisha Samurai 3Group; effective interest held, 2025 and 2024 respectivelyPDF p. 193 | Special purpose entity – Investment in real estate; Japan; Effective interests held by Group: 100% / 100% | |
| Godo Kaisha Samurai 4Group; effective interest held, 2025 and 2024 respectivelyPDF p. 193 | Special purpose entity – Investment in real estate; Japan; Effective interests held by Group: 100% / 100% | |
| Godo Kaisha Samurai 5Group; effective interest held, 2025 and 2024 respectivelyPDF p. 193 | Special purpose entity – Investment in real estate; Japan; Effective interests held by Group: 100% / 100% | |
| Godo Kaisha Samurai 6Group; effective interest held, 2025 and 2024 respectivelyPDF p. 193 | Special purpose entity – Investment in real estate; Japan; Effective interests held by Group: 100% / 100% | |
| Godo Kaisha Samurai 7Group; effective interest held, 2025 and 2024 respectivelyPDF p. 193 | Special purpose entity – Investment in real estate; Japan; Effective interests held by Group: 100% / 100% | |
| Godo Kaisha Samurai 8Group; effective interest held, 2025 and 2024 respectivelyPDF p. 193 | Special purpose entity – Investment in real estate; Japan; Effective interests held by Group: 100% / 100% | |
| Godo Kaisha Samurai 9Group; effective interest held, 2025 and 2024 respectivelyPDF p. 193 | Special purpose entity – Investment in real estate; Japan; Effective interests held by Group: 100% / 100% | |
| Godo Kaisha Samurai 10Group; effective interest held, 2025 and 2024 respectivelyPDF p. 193 | Special purpose entity – Investment in real estate; Japan; Effective interests held by Group: 100% / 100% | |
| Godo Kaisha Samurai 11Group; effective interest held, 2025 and 2024 respectivelyPDF p. 193 | Special purpose entity – Investment in real estate; Japan; Effective interests held by Group: 100% / 100% | |
| Godo Kaisha Samurai 12Group; effective interest held, 2025 and 2024 respectivelyPDF p. 193 | Special purpose entity – Investment in real estate; Japan; Effective interests held by Group: 100% / 100% | |
| Godo Kaisha Samurai 13Group; effective interest held, 2025 and 2024 respectivelyPDF p. 193 | Special purpose entity – Investment in real estate; Japan; Effective interests held by Group: 100% / 100% | |
| Godo Kaisha Samurai 14Group; effective interest held, 2025 and 2024 respectivelyPDF p. 193 | Special purpose entity – Investment in real estate; Japan; Effective interests held by Group: 100% / 100% | |
| Godo Kaisha Samurai 15Group; effective interest held, 2025 and 2024 respectivelyPDF p. 194 | Special purpose entity – Investment in real estate; Japan; Effective interests held by Group: 100% / 100% | |
| Godo Kaisha Samurai 16Group; effective interest held, 2025 and 2024 respectivelyPDF p. 194 | Special purpose entity – Investment in real estate; Japan; Effective interests held by Group: 100% / 100% | |
| Godo Kaisha Samurai 17Group; effective interest held, 2025 and 2024 respectivelyPDF p. 194 | Special purpose entity – Investment in real estate; Japan; Effective interests held by Group: 100% / 100% | |
| Godo Kaisha Samurai 18Group; effective interest held, 2025 and 2024 respectivelyPDF p. 194 | Special purpose entity – Investment in real estate; Japan; Effective interests held by Group: 100% / 100% | |
| Parkway Life Malaysia Pte. Ltd.Group; effective interest held, 2025 and 2024 respectivelyPDF p. 194 | Investment holding; Singapore; Effective interests held by Group: 100% / 100% | |
| Parkway Life Malaysia Sdn. Bhd.Group; effective interest held, 2025 and 2024 respectivelyPDF p. 194 | Special purpose entity – Investment in real estate; Malaysia; Effective interests held by Group: 100% / 100% | |
| Parkway Life Nova Pte. Ltd.Group; effective interest held, 2025 and 2024 respectivelyPDF p. 194 | Investment holding; Singapore; Effective interests held by Group: 100% / 100% | |
| Parkway Life Soleil SASGroup; effective interest held, 2025 and 2024 respectivelyPDF p. 194 | Investment holding; France; Effective interests held by Group: 100% / 100% | |
| Parkway Life Santé SCGroup; effective interest held, 2025 and 2024 respectivelyPDF p. 194 | Investment holding; France; Effective interests held by Group: 100% / 100% | |
| Parkway Life Santé 1 SCIGroup; effective interest held, 2025 and 2024 respectivelyPDF p. 194 | Special purpose entity – Investment in real estate; France; Effective interests held by Group: 100% / 100% | |
| Parkway Life Santé 2 SCIGroup; effective interest held, 2025 and 2024 respectivelyPDF p. 194 | Special purpose entity – Investment in real estate; France; Effective interests held by Group: 100% / 100% | |
| Parkway Life Santé 3 SCIGroup; effective interest held, 2025 and 2024 respectivelyPDF p. 194 | Special purpose entity – Investment in real estate; France; Effective interests held by Group: 100% / 100% | |
| Parkway Life Santé 4 SCIGroup; effective interest held, 2025 and 2024 respectivelyPDF p. 194 | Special purpose entity – Investment in real estate; France; Effective interests held by Group: 100% / 100% | |
| Parkway Life Santé 5 SCIGroup; effective interest held, 2025 and 2024 respectivelyPDF p. 194 | Special purpose entity – Investment in real estate; France; Effective interests held by Group: 100% / 100% | |
| Parkway Life Santé 6 SCIGroup; effective interest held, 2025 and 2024 respectivelyPDF p. 195 | Investment holding; France; Effective interests held by Group: 100% / 100% | |
| Parkway Life Santé 7 SCIGroup; effective interest held, 2025 and 2024 respectivelyPDF p. 195 | Investment holding; France; Effective interests held by Group: 100% / 100% | |
| Parkway Life Santé 8 SCIGroup; effective interest held, 2025 and 2024 respectivelyPDF p. 195 | Investment holding and Special purpose entity – Investment in real estate; France; Effective interests held by Group: 100% / 100% | |
| Parkway Life Santé 9 SCIGroup; effective interest held, 2025 and 2024 respectivelyPDF p. 195 | Investment holding and Special purpose entity – Investment in real estate; France; Effective interests held by Group: 100% / 100% | |
| Champs InvestGroup; effective interest held, 2025 and 2024 respectivelyPDF p. 195 | Special purpose entity – Investment in real estate; France; Effective interests held by Group: – / 100% | |
| Saint Marcel InvestGroup; effective interest held, 2025 and 2024 respectivelyPDF p. 195 | Special purpose entity – Investment in real estate; France; Effective interests held by Group: – / 100% | |
| Villers-Semeuse InvestGroup; effective interest held, 2025 and 2024 respectivelyPDF p. 195 | Special purpose entity – Investment in real estate; France; Effective interests held by Group: – / 100% | |
| SCI TurquoiseGroup; effective interest held, 2025 and 2024 respectivelyPDF p. 195 | Special purpose entity – Investment in real estate; France; Effective interests held by Group: – / 100% | |
| Parkway Life MTN Pte. Ltd.Group; effective interest held, 2025 and 2024 respectivelyPDF p. 195 | Provision of financial and treasury services; Singapore; Effective interests held by Group: 100% / 100% | |
Ownership interests and geographic information follow the annual report. Comparative years and footnote markers retain the report’s notation.
Senior executives
| Item | Value | Period / scope | Source |
|---|---|---|---|
| MR. YONG YEAN CHAU | Chief Executive Officer and Executive Director | Parkway Trust Management Limited (Manager of PLife REIT) | PDF p. 25 |
| MS. TEO CHIN PING | Head, Projects | Parkway Trust Management Limited (Manager of PLife REIT) | PDF p. 27 |
Extracted from Annual Report 2025 and checked against the cited pages; see the original report for full context.
Related parties, people & properties
| Item | Value | Period / scope | Source |
|---|---|---|---|
| Parkway Hospitals Singapore Pte. Ltd. | 79,718 $'000 | FY2025 aggregate value of all interested person transactions (excluding <$100,000 and Unitholders' mandate); Nil under Unitholders' mandate | PDF p. 236 |
| Gleneagles Hospital Kuala Lumpur (a branch of Pantai Medical Centre Sdn. Bhd.) | 174 $'000 | FY2025 aggregate value of all interested person transactions; Nil under Unitholders' mandate | PDF p. 236 |
| Pantai Medical Centre Sdn. Bhd. | 6,088 $'000 | FY2025 aggregate value of all interested person transactions; Nil under Unitholders' mandate | PDF p. 236 |
| Parkway Trust Management Limited | 14,484 $'000 | FY2025 aggregate value of all interested person transactions; Nil under Unitholders' mandate | PDF p. 236 |
| HSBC Institutional Trust Services (Singapore) Limited | 409 $'000 | FY2025 aggregate value of all interested person transactions; Nil under Unitholders' mandate | PDF p. 236 |
| Item | Value | Period / scope | Source |
|---|---|---|---|
| Corporate guarantee | $16.2 million | Trust; as at 31 December 2025 (2024: $16.2 million) · As at 2025-12-31 | PDF p. 199 |
| Item | Value | Period / scope | Source |
|---|---|---|---|
| Ms. Cheah Sui Ling | 113,000 S$ | FY2025 total directors' fees, non-executive director of the Manager | PDF p. 83 |
| Mr. Ho Kian Guan(1) | 109,600 S$ | FY2025 total directors' fees | PDF p. 83 |
| Ms. Theresa Goh Cheng Keow(3) | 105,485 S$ | FY2025 total directors' fees | PDF p. 83 |
| Yong Yean Chau | S$1,702,010 | FY2025 CEO and Executive Director total remuneration | PDF p. 83 |
| Item | Value | Period / scope | Source |
|---|---|---|---|
| MOUNT ELIZABETH | Leasehold of 67 years | Singapore property; hospital; lessee Parkway Hospitals Singapore Pte Ltd | PDF p. 40 |
| GLENEAGLES | Leasehold of 75 years | Singapore property; hospital; lessee Parkway Hospitals Singapore Pte Ltd | PDF p. 40 |
| PARKWAY EAST | Leasehold of 75 years | Singapore property; hospital; lessee Parkway Hospitals Singapore Pte Ltd | PDF p. 40 |
| Item | Value | Period / scope | Source |
|---|---|---|---|
| SUBSEQUENT EVENTS | On 2 February 2026, the Manager declared a distribution of 7.64 cents per unit in respect of the period 1 July 2025 to 31 December 2025 which is payable on 10 March 2026. | Note 26, after reporting date · As at 2026-02-02 | PDF p. 235 |
| SUBSEQUENT EVENTS | the Trust executed a facility agreement for a 10-year, committed and unsecured loan, amounting to JPY8.8 billion (approximately S$72.0 million). | Note 26, event on 20 February 2026 · As at 2026-02-20 | PDF p. 235 |
Extracted from Annual Report 2025 and checked against the cited pages; see the original report for full context.
Corporate information